med-device-excellence-award-1.jpg Myla middleware recognized for groundbreaking innovation in In Vitro Diagnostics.
Asia
Europe, Middle East, Africa
North America
bioMérieux Gains International Modification/Matrix Extension Approval for its Automated Solution: VIDAS® UP Salmonella Phage Technology (SPT)
29 March, 2012
AOAC Performance Tested MethodSM 071101 Approval Underscores VIDAS Excellence in Food Safety Testing
bioMérieux - 2011 Financial Results
13 March, 2012
The Board of Directors of bioMérieux, a global leader in the field of in vitro diagnostics, met today and approved the consolidated financial statements for the year ended December 31, 2011. The meeting was chaired by Jean-Luc Belingard and attended by the Statutory Auditors, who have audited the financial statements and will be issuing an unqualified opinion in the coming days.
bioMérieux - 2011 Business Review
24 January, 2012
bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for fourth-quarter and full-year 2011.
bioMérieux Gains International Approval for VITEK® 2 Compact Gram Negative Card
29 December, 2011
AOAC® Official Methods(SM) approval adds new level of confidence for food safety testing
bioMérieux - Information on 2011 Sales Objective
07 December, 2011
bioMérieux, a world leader in the field of in vitro diagnostics, announces that, based on preliminary data, sales growth at constant exchange rates, for the eleven months ended November 30, 2011, amounted to 5.5%, with 3.4% organic growth.
bioMérieux VIDAS® Listeria monocytogenes Xpress Assay and VIDAS® UP Salmonella Kits Gain International Approvals
25 October, 2011
bioMérieux, a world leader in the field of in vitro diagnostics, today announced it has received international recognition for two new solutions that will help protect consumers from food-borne illnesses.
bioMérieux Business Review for the Nine Months Ended September 30, 2011
20 October, 2011
bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the nine months ended September 30, 2011.
bioMérieux Demonstrates Emerging Technologies that Impact Speed of Diagnostics for Infectious Disease Clinicians
20 October, 2011
bioMerieux shares new diagnostic tools at the 49th Annual Meeting of the Infectious Diseases Society of America - visit IDSA booth #916
bioMérieux - First-Half Results at June 30, 2011
06 September, 2011
The Board of Directors of bioMerieux, a world leader in the field of in vitro diagnostics, met today to approve the consolidated financial statements for the six months ended June 30, 2011. The meeting was chaired by Jean-Luc Belingard and attended by the Statutory Auditors, who had performed a limited review of the financial statements.